These data support a model where BSG protein expression is associated with basal-like breast cancer cells, whereas luminal and HER2-positive breast cancer cells with low BSG expression have an increased dependency on estrogen receptor-driven FOXA1 transcriptional activity. Here, BSG is linked to breast cancer.